Product NDC: | 0024-5860 |
Proprietary Name: | Clolar |
Non Proprietary Name: | clofarabine |
Active Ingredient(s): | 1 mg/mL & nbsp; clofarabine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0024-5860 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021673 |
Marketing Category: | NDA |
Start Marketing Date: | 20130401 |
Package NDC: | 0024-5860-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) > 20 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0024-5860-01 |
Proprietary Name | Clolar |
Package Description | 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) > 20 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0024-5860 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clofarabine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130401 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | CLOFARABINE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |